Long-Term Followup of Dextranomer/Hyaluronic Acid Injection for Vesicoureteral Reflux: Late Failure Warrants Continued Followup

Journal of Urology

Volumn 181, Issue 4, 2009, Pages 1869-1875

  Lee, Eugene K ^a   Gatti, John M ^a   DeMarco, Romano T ^a   Murphy, J Patrick ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

deflux; dextranomer hyaluronic acid copolymer; follow up studies; vesico ureteral reflux

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXTRANOMER; HYALURONIC ACID;

ARTICLE; CHILD; COST EFFECTIVENESS ANALYSIS; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MICTURITION; MICTURITION CYSTOURETHROGRAPHY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT RESPONSE; URINARY TRACT INFECTION; VESICOURETERAL REFLUX;

CHILD; CHILD, PRESCHOOL; DEXTRANS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INFANT; INJECTIONS; MALE; RETROSPECTIVE STUDIES; TIME FACTORS; VESICO-URETERAL REFLUX;

EID: 62049084328     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.12.005     Document Type: Article

References (17)

1. Wheeler D., Vimalachandra D., Hodson E., Roy L., Smith G., and Craig J. Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomized controlled trials. Arch Dis Child 88 (2003) 688
2. Elder J.S., Peters C.A., Arant Jr. B.S., Ewalt D.H., Hawtrey C.E., Hurwitz R.S., et al. Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children. J Urol 157 (1997) 1846
3. Lomberg H. Properties of Escherichia coli in patients with renal scarring. J Infect Dis 159 (1989) 579
4. Majd M., Rushton H.G., Jantausch B., and Wiedermann B.L. Relationship among vesicoureteral reflux, p-fimbriated Escherichia coli, and acute pyelonephritis in children with febrile urinary tract infection. J Pediatr 119 (1991) 578
5. Matouschek E. Die behandlung des vesikorenalen refluxes durch transurethrale einspritzung von Teflon paste. Urologe A 20 (1981) 263
6. Lendvay T.S., Sorensen M., Cowan C.A., Joyner B.D., Mitchell M.M., and Grady R.W. The evolution of vesicoureteral reflux management in the era of dextranomer/hyaluronic acid copolymer: a Pediatric Health Information System database study. J Urol 176 (2006) 1864
7. Routh J.C., Reinberg Y., Ashley R.A., Inman B.A., Wolpert J.J., Vandersteen D.R., et al. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection. J Urol 178 (2007) 1702
8. Kirsch A., Perez-Brayfield M., Smith E.A., and Scherz H.C. The modified STING procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 171 (2004) 2413
9. Elder J.S., Diaz M., Caldamone A.A., Cendron M., Greenfield S., Hurwitz R., et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 175 (2006) 716
10. Yucel S., Gupta A., and Snodgrass W. Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 177 (2007) 1505
11. Lackgren G., Wahlin N., Skoldenberg E., and Stenberg A. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 166 (2001) 1887
12. Benoit R.M., Peele P.B., and Docimo S.G. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management. J Urol 176 (2006) 1588
13. Benoit R.M., Peele P.B., Cannon Jr. G.M., and Docimo S.G. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 2. Reflux correction at the time of diagnosis as a substitute for traditional management. J Urol 176 (2006) 2649
14. Lorenzo A.J., Pippi Salle J.L., Barroso U., Cook A., Grober E., Wallis M.C., et al. What are the most powerful determinants of endoscopic vesicoureteral reflux correction?. Multivariate analysis of a single institution experience during 6 years. J Urol 176 (2006) 1851
15. Elmore J.M., Kirsch A.J., Heiss E.A., Gilchrist A., and Scherz H.C. Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation. J Urol 179 (2008) 2364
16. Chi A., Gupta A., and Snodgrass W. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 179 (2008) 1966
17. Sedberry-Ross S., Rice D.C., Pohl H.G., Belman A.B., Majd M., and Rushton H.G. Febrile urinary tract infections in children with an early negative voiding cystourethrogram after treatment of vesicoureteral reflux with dextranomer/hyaluronic acid. J Urol, part 2 180 (2008) 1605